Literature DB >> 10386654

A reduction in the AAPM TG-36 reported peripheral dose distributions with tertiary multileaf collimation. American Association of Physicists in Medicine Task Group 36.

S Mutic1, E E Klein.   

Abstract

PURPOSE: The American Association of Physicists in Medicine Task Group 36 (AAPM TG-36) data can be used to estimate peripheral dose (PD) distributions outside the primary radiation field. However, the report data apply to linear accelerators not equipped with tertiary multileaf collimators (MLCs). Peripheral dose distributions consist of internal scatter, collimation scatter, transmission through collimation, head leakage, and room scatter. Tertiary MLCs may significantly reduce the PD due to a reduction in collimation scatter, transmission through collimation, and head leakage. Measurements were performed on a multimodality linear accelerator, equipped with a tertiary MLC, to determine PD distributions as a function of energy, field size, distance from the primary radiation field edge, MLC position, and collimator orientation. METHODS AND MATERIALS: Measurements were made using an ionization chamber embedded in a 20 x 40 x 120-cm3 water-equivalent plastic phantom with the secondary collimator and MLC settings of 10 x 10, 15 x 15, 20 x 20, 25 x 25 cm2, and with the MLC fully retracted. Data were taken along the longitudinal axis of the machine for 6 and 18 MV photons. Peripheral dose distributions were evaluated with the collimator set to 180 and 90 degrees. Rotation of the collimator allowed measurements parallel and orthogonal to the direction of motion of the MLC.
RESULTS: For both photon energies, peripheral doses measured on a MLC machine were lower than the TG-36 data. When the collimator is rotated by 90 degrees, placing the lower jaws and the MLC leaves along the plane of interest, PD was reduced by as much as a factor of three compared with PDs measured with the MLC fully retracted and the collimator rotated to 180 degrees. PDs measured with the MLC fully retracted and collimator rotated to 180 degrees were comparable to the TG-36 data. Measured PDs were lower when the MLC was used to shape the field than when the MLC was fully retracted.
CONCLUSION: A strategic orientation of the collimator with a tertiary MLC can reduce PD distributions by more than a factor of two. This decrease significantly lessens or eliminates the need for external lead shielding to reduce the critical organ dose. This method can be used even when Lipowitz metal blocking (such as for mantle fields) is used, with the MLC leaves oriented along the longitudinal plane.

Entities:  

Mesh:

Year:  1999        PMID: 10386654     DOI: 10.1016/s0360-3016(99)00092-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  18 in total

1.  Evaluation of the peripheral dose in stereotactic radiotherapy and radiosurgery treatments.

Authors:  Erika Di Betta; Laura Fariselli; Achille Bergantin; Federica Locatelli; Antonella Del Vecchio; Sara Broggi; Maria Luisa Fumagalli
Journal:  Med Phys       Date:  2010-07       Impact factor: 4.071

2.  Conceptus dose from involved-field radiotherapy for Hodgkin's lymphoma on a linear accelerator equipped with MLCs.

Authors:  Michalis Mazonakis; Efrossini Lyraraki; Charalambos Varveris; Elina Samara; Kyveli Zourari; John Damilakis
Journal:  Strahlenther Onkol       Date:  2009-06-09       Impact factor: 3.621

3.  Technical Report: Evaluation of peripheral dose for flattening filter free photon beams.

Authors:  E L Covington; T A Ritter; J M Moran; A M Owrangi; J I Prisciandaro
Journal:  Med Phys       Date:  2016-08       Impact factor: 4.071

4.  Measurement and modeling of out-of-field doses from various advanced post-mastectomy radiotherapy techniques.

Authors:  Jihyung Yoon; David Heins; Xiaodong Zhao; Mary Sanders; Rui Zhang
Journal:  Phys Med Biol       Date:  2017-11-13       Impact factor: 3.609

5.  A study of the shielding used to reduce leakage and scattered radiation to the fetus in a pregnant patient treated with a 6-MV external X-ray beam.

Authors:  Bin Han; Bryan Bednarz; X George Xu
Journal:  Health Phys       Date:  2009-12       Impact factor: 1.316

6.  A feasibility study to calculate unshielded fetal doses to pregnant patients in 6-MV photon treatments using Monte Carlo methods and anatomically realistic phantoms.

Authors:  Bryan Bednarz; X George Xu
Journal:  Med Phys       Date:  2008-07       Impact factor: 4.071

7.  Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer.

Authors:  Jonas D Fontenot; Andrew K Lee; Wayne D Newhauser
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-06-01       Impact factor: 7.038

Review 8.  A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction.

Authors:  X George Xu; Bryan Bednarz; Harald Paganetti
Journal:  Phys Med Biol       Date:  2008-06-09       Impact factor: 3.609

9.  Consideration of the radiation dose delivered away from the treatment field to patients in radiotherapy.

Authors:  Michael L Taylor; Tomas Kron
Journal:  J Med Phys       Date:  2011-04

10.  Variation of beam characteristics between three different wedges from a dual-energy accelerator.

Authors:  C Varatharaj; M Ravikumar; S Sathiyan; Sanjay S Supe
Journal:  J Med Phys       Date:  2011-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.